Indivior Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDV and other ETFs, options, and stocks.

About INDV

Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company was founded on December 23, 2014 and is headquartered in North Chesterfield, VA. 

CEO
Joseph J. Ciaffoni
CEOJoseph J. Ciaffoni
Employees
838
Employees838
Headquarters
North Chesterfield, Virginia
HeadquartersNorth Chesterfield, Virginia
Founded
2014
Founded2014
Employees
838
Employees838

INDV Key Statistics

Market cap
5.07B
Market cap5.07B
Price-Earnings ratio
20.57
Price-Earnings ratio20.57
Dividend yield
Dividend yield
Average volume
2.82M
Average volume2.82M
High today
High today
Low today
Low today
Open price
$39.65
Open price$39.65
Volume
0.00
Volume0.00
52 Week high
$40.81
52 Week high$40.81
52 Week low
$10.63
52 Week low$10.63

Stock Snapshot

The current Indivior Pharmaceuticals(INDV) stock price is $40.81, with a market capitalization of 5.07B. The stock trades at a price-to-earnings (P/E) ratio of 20.57.

On 2026-05-07, Indivior Pharmaceuticals(INDV) stock opened at $39.65, reached a high of —, and a low of —.

The Indivior Pharmaceuticals(INDV)'s current trading volume is 0, compared to an average daily volume of 2.82M.

In the last year, Indivior Pharmaceuticals(INDV) shares hit a 52-week high of $40.81 and a 52-week low of $10.63.

In the last year, Indivior Pharmaceuticals(INDV) shares hit a 52-week high of $40.81 and a 52-week low of $10.63.

INDV News

Simply Wall St 2d
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News

Indivior Pharmaceuticals (INDV) is back on investors' radars after a busy stretch that combined strong Q1 2026 results, a raised full year revenue outlook, and...

A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Q1 Beat, Raised 2026 Guidance And Buyback News
Nasdaq 6d
Indivior Q1 2026 Earnings Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

Indivior Q1 2026 Earnings Transcript

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own INDV. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.